DE1374910U - - Google Patents

Info

Publication number
DE1374910U
DE1374910U DENDAT1374910D DE1374910DU DE1374910U DE 1374910 U DE1374910 U DE 1374910U DE NDAT1374910 D DENDAT1374910 D DE NDAT1374910D DE 1374910D U DE1374910D U DE 1374910DU DE 1374910 U DE1374910 U DE 1374910U
Authority
DE
Germany
Prior art keywords
dur
dlu
uin
dor
major
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1374910D
Other languages
German (de)
English (en)
Publication of DE1374910U publication Critical patent/DE1374910U/de
Active legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
DENDAT1374910D Active DE1374910U (Direct)

Publications (1)

Publication Number Publication Date
DE1374910U true DE1374910U (Direct)

Family

ID=687744

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1374910D Active DE1374910U (Direct)

Country Status (1)

Country Link
DE (1) DE1374910U (Direct)

Similar Documents

Publication Publication Date Title
FI850078L (fi) N-(4-piperidinyl)-bicykliska -kondenserade 2-imidazolaminderivat.
US11406617B2 (en) Compounds for the treatment of bovine or swine respiratory disease
DE69317494D1 (de) Zusammensetzungen, die mono oder polyhydroxylierte Aminosäuren zur Behandlung des Insulinunabhängigen Diabetes Mellitus enthalten
KR101462060B1 (ko) 치환된 4-페닐테트라하이드로이소퀴놀린, 이의 제조방법,약제로서의 이의 용도 및 이를 함유하는 약제
DE1374910U (Direct)
US20220041547A1 (en) Compounds Useful for Treating a Mannheimia Haemolytica or Histophilus Somni Infection
ATE336254T1 (de) Zusammensetzungen zur behandlung von irds oder ards die 3-(calcopropylmethoxy)-n-(3,5-dichloro-4-pyridi yl)-4-(difluoromethoxy) benzamid und lungensurfactant enthalten
DK582588A (da) Infektionsforhindrende forbindelser og fremgangsmaade til deres anvendelse
Hammond et al. The occurrence of a second asexual generation in the life cycle of Eimeria bovis in calves
MA27277A1 (fr) Le pentafluorosulfanyl-benzoylguanidine, methode pour sa production et son utilisation comme medicament ou agent de diagnostique et medicament le contenant
ES423711A1 (es) Procedimiento para la obtencion de derivados de tetrahidro- piridina y piperidina.
US6352726B1 (en) Method of killing protozoa
DE69522702D1 (de) Eine lagerstabile wässrige lösung zur infusion die einen thrombininhibitor enthält
US3943246A (en) Organic compounds
FR2601680B1 (fr) Inhibiteur de la synthese proteique, procede d'isolement, utilisation et compositions pharmaceutiques en contenant
ATE190484T1 (de) Arzneimittel zur behandlung von durch babesia verursachten protozoeninfektionen
Hirsch et al. Subarachnoid hemorrhage following ephedrine and MAO inhibitor
WO2000006535A1 (en) Tyrosine-derived compounds as calcium channel antagonists
Guarro Comments on recent human infections caused by ascomycetes
RU2234939C1 (ru) Лекарственный препарат сублингвальных таблеток, содержащий интерферон-альфа, и способ его получения
WO2025046130A3 (en) T cell broad betacoronavirus vaccine
Schnitker et al. Osteomyelitis of the skull—its treatment with penicillin and repair of the defect with tantalum
Greey et al. Penicillin agar pastilles
EP1470104A2 (de) Verbindungen, die faktor xa-aktivität inhibieren
Ezeibe et al. BLOOD COAGULATION TIME AS A POSSIBLE TOOL FOR THE CLINICAL DIFFERENTIATION OF CANINE DISTEMPER AND TRYPANOSOMOSIS